| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/1996 | US5494796 Using genus- and species-specific oligonucleotide probes |
| 02/27/1996 | US5494792 Kainate-binding, human CNS receptors of the EAA2 family |
| 02/27/1996 | US5494790 Complementary dna encoding specific sialyltransferase |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/26/1996 | CA2156231A1 Process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification, a diagnostic assay employing said process, a kit anda container |
| 02/22/1996 | WO1996005353A1 A method for desizing cellulose-containing fabric |
| 02/22/1996 | WO1996005325A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005319A1 Genetically engineered cells that produce dopamine |
| 02/22/1996 | WO1996005318A1 Mutated penicillin g acylase genes |
| 02/22/1996 | WO1996005317A1 Ga4 dna, protein and methods of use |
| 02/22/1996 | WO1996005316A1 Overproduction and purification of soluble pha synthase |
| 02/22/1996 | WO1996005315A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 02/22/1996 | WO1996005314A2 Protein toxins active against lepidopteran pests |
| 02/22/1996 | WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 02/22/1996 | WO1996005312A1 Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease |
| 02/22/1996 | WO1996005311A1 Biologically active porcine somatotropin polypeptide and methods of using the same |
| 02/22/1996 | WO1996005310A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 02/22/1996 | WO1996005309A2 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 02/22/1996 | WO1996005308A1 Method for diagnosing a predisposition for breast and ovarian cancer |
| 02/22/1996 | WO1996005307A2 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
| 02/22/1996 | WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
| 02/22/1996 | WO1996005305A1 Use of zrk peptide sequences in contraception |
| 02/22/1996 | WO1996005304A1 Integrin blocking molecules |
| 02/22/1996 | WO1996005303A1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 02/22/1996 | WO1996005302A1 G protein coupled receptor protein, production, and use thereof |
| 02/22/1996 | WO1996005301A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | WO1996005300A2 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 02/22/1996 | WO1996005299A1 Dna vector for bone-specific gene expression |
| 02/22/1996 | WO1996005298A1 Antitumor antisense oligonucleotides |
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005296A1 Method of preparing and amplifying nucleic acids |
| 02/22/1996 | WO1996005295A2 An improved cleaning composition |
| 02/22/1996 | WO1996005293A1 Molecular presenting system |
| 02/22/1996 | WO1996005292A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof |
| 02/22/1996 | WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 02/22/1996 | WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005226A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
| 02/22/1996 | WO1996005215A1 Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides |
| 02/22/1996 | WO1996005214A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996004947A1 Particle delivery |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN |
| 02/22/1996 | WO1996004925A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 02/22/1996 | WO1996004790A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 02/22/1996 | WO1996004789A1 A method of selectively destroying neoplastic cells |
| 02/22/1996 | WO1996004788A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | WO1996004781A1 Plant group 2 promoters and uses thereof |
| 02/22/1996 | WO1996000795A3 Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids |
| 02/22/1996 | WO1995034665A3 Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells |
| 02/22/1996 | WO1995025171A3 Dna sequences for matrix metalloproteases, their production and use |
| 02/22/1996 | DE4425645A1 New lysostaphin gene with deletion in pro-segment repeat region |
| 02/22/1996 | DE19503359C1 Plants with increased tolerance towards stress |
| 02/22/1996 | CA2197753A1 Ga4 dna, protein and methods of use |
| 02/22/1996 | CA2197712A1 Vaccines containing borrelia burgdorferi ospg |
| 02/22/1996 | CA2197569A1 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197446A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | CA2197420A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2197203A1 An improved cleaning composition |
| 02/22/1996 | CA2197117A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2196788A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2196080A1 Protein toxins active against lepidopteran pests |
| 02/22/1996 | CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain |
| 02/22/1996 | CA2195768A1 G protein coupled receptor protein, production, and use thereof |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0697462A2 Process for producing Glycine-N-Methyl Transferase using recombinant DNA |
| 02/21/1996 | EP0697461A1 Recombinant thermostable enzyme which releases trehalose from non-reducing saccharide |
| 02/21/1996 | EP0697414A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/21/1996 | EP0540573B1 Assay of free and complexed prostate-specific antigen (psa) |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492888 Method of using soluble human interleukin-1 receptors to suppress immune responses |
| 02/20/1996 | US5492830 Enzymatic resolution of α-tertiary carboxylic acid esters |
| 02/20/1996 | US5492825 Mammalian inward rectifier potassium channel cDNA, IRK1, corresponding vectors, and transformed cells |
| 02/20/1996 | US5492824 Interleukins |
| 02/20/1996 | US5492823 Method for direct cloning and producing the BsoBI restriction endonuclease in E. coli |
| 02/20/1996 | US5492820 Plasmids for the production of transgenic plants that are modified in habit and yield |
| 02/20/1996 | US5492813 Muteins of β-galactosidase fragments having increased activity |
| 02/20/1996 | US5492809 Mutations rendering platelet glycoprotein Ib-α less reactive |
| 02/20/1996 | US5492808 Means for detecting familial colon cancer (FCC) |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/17/1996 | CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 02/15/1996 | WO1996004557A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | WO1996004404A1 Method and apparatus for performing amplification of nucleic acid on supports |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004402A1 Detection of mycobacteria |